MedX Health Corp. obtains receipt for final prospectus



    /THIS NEWS RELEASE IS NOT FOR DISSEMINATION IN THE UNITED STATES OR TO
    ANY UNITED STATES NEWS SERVICES/

    MISSISSAUGA, ON, Jan. 11 /CNW/ - MedX Health Corp. ("MedX") announces
that it has obtained a receipt for a final prospectus dated January 10, 2008
with respect to its best efforts offering of units from the securities
commissions in Ontario, British Columbia, Alberta and Manitoba.
    The offering (the "Offering") for a minimum of $4,000,000 and a maximum
of $7,000,000 of units of MedX (the "Units") has been priced at $0.80 per
Unit. Each Unit is comprised of one common share and one warrant to purchase
one common share for $0.90 for two years. Research Capital Corporation is
acting as agent on a best efforts basis to sell a minimum of 5,000,000 Units
and a maximum of 8,750,000 Units.
    Closing of the Offering is also conditional upon MedX receiving
conditional approval to list its common shares on the TSX Venture Exchange.
    The net proceeds of the Offering will be used for expansion of
distribution network, marketing program, product development for new dental,
rehabilitation and wound care products, research and development for wound
care study and for working capital purposes.
    MedX's final prospectus is available on the SEDAR website at
http://www.sedar.com.

    The TSX Venture Exchange does not accept responsibility for the adequacy
    or accuracy of this press release.

    This news release is not for dissemination in the United States or to any
United States news services. This press release is not an offer to sell or a
solicitation of an offer to buy the units, nor shall there be any sales of the
units in any jurisdiction in which such offer, solicitation, or sale would be
unlawful. The securities offered pursuant to the public offering have not been
and will not be registered under the United States Securities Act of 1933, as
amended, and may not be offered or sold in the United States absent
registration or any applicable exemption from the registration requirement of
such Act.

    %SEDAR: 00017466E




For further information:

For further information: Phil Passy, President and Chief Executive
Officer, Phone: (905) 826-0766, Email: info@medxhealth.com

Organization Profile

MedX Health Corp.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890